Arikayce (amikacin liposome suspension for oral inhalation) — Medica
Cystic fibrosis with Pseudomonas aeruginosa infection
Initial criteria
- Pseudomonas aeruginosa present in culture of the airway (e.g., sputum, oropharyngeal, or bronchoalveolar lavage culture)
- prescribed by or in consultation with a pulmonologist or physician specializing in cystic fibrosis
Approval duration
1 year